Poteligeo side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Poteligeo (mogamulizumab-kpkc). Common side effects include adult t-cell lymphoma/leukaemia among females and infection among males.
The phase IV clinical study is created by eHealthMe based on 1,222 reports from the FDA, and is updated regularly.
What is Poteligeo?
Poteligeo has active ingredients of mogamulizumab-kpkc. eHealthMe is studying from 1,222 Poteligeo users. Check the latest studies of Poteligeo.
1,222 people who take Poteligeo and have side effects are studied.
What are the common side effects of Poteligeo, by gender? *
What are the common side effects of Poteligeo, by age (0-1 to 60+)? *
What are the common side effects of Poteligeo, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Poteligeo?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on mogamulizumab-kpkc (the active ingredients of Poteligeo) and Poteligeo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Poteligeo:
- Poteligeo (1,222 reports)
All Poteligeo side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Constipation and Urine Output - Decreased - 7 seconds ago
- Could Combivent cause Acne? - 10 seconds ago
- Multiple Myeloma and Catheter Related Complication - 18 seconds ago
- Could Takhzyro cause The Flu? - 20 seconds ago
- Drug interactions of Ibuprofen and Myorisan - 22 seconds ago
- Could Meloxicam cause Blood Magnesium Decreased? - 28 seconds ago
- Could Ms Contin cause Blood Magnesium Decreased? - 30 seconds ago
- Could Aredia cause Ankylosing Spondylitis? - 48 seconds ago
- Could Cytarabine cause Systemic Mycosis? - a minute ago
- Could Escitalopram Oxalate cause Bruxism? - a minute ago